Rosen & Barkin's 5-Minute Emergency Medicine Consult (481 page)

Read Rosen & Barkin's 5-Minute Emergency Medicine Consult Online

Authors: Jeffrey J. Schaider,Adam Z. Barkin,Roger M. Barkin,Philip Shayne,Richard E. Wolfe,Stephen R. Hayden,Peter Rosen

Tags: #Medical, #Emergency Medicine

BOOK: Rosen & Barkin's 5-Minute Emergency Medicine Consult
6.1Mb size Format: txt, pdf, ePub
DESCRIPTION
  • Acute glomerulonephritis (AGN) is acute inflammatory damage to glomerulus, associated with:
    • Abrupt onset of hematuria with or without RBC casts
    • Acute renal failure manifested by edema, hypertension, azotemia, decline in urine output
    • Variable proteinuria
    • Active urine sediment (RBC casts)
  • Exact mechanism of AGN unclear:
    • Combination of autoimmune reactivity to specific antigens at renal glomeruli
    • Characterized by crescent formation secondary to nonspecific injury at the glomerular wall
ETIOLOGY
  • Poststreptococcal glomerulonephritis (PSGN):
    • A postinfectious cause of acute nephritic syndrome, resulting from group A β-hemolytic streptococci
    • Considered a nonsuppurative complication (antibiotic treatment does not prevent this complication)
    • Occurs when immune complexes create hump-shaped subepithelial deposits in renal glomeruli
    • Most commonly affects patients between ages 3 and 15 yr but can occur at any age
    • Incidence of nephritis is 5–10% after pharyngitis and 25% after skin infections.
    • Consider PSGN in the setting of new-onset proteinuria, RBC casts, edema, and any recent infection.
    • Latent period between infection and onset of nephritis helps differentiate between PSGN and IgA nephropathy:
      • 1–3 wk in pharyngeal infection
      • 2–4 wk in cutaneous infection
    • Renal biopsy is usually not necessary for diagnosis.
    • Low complement (C3) for 6–8 wk
    • Can progress to severe renal failure if underlying infection goes untreated
    • Prognosis:
      • Excellent; >95% recover spontaneously with normalization of renal function within 6–8 wk, even with dialysis.
      • Hematuria usually resolves in 3–6 mo.
      • Transient nephrotic phase in 20% of patients during resolution of illness
      • End-stage renal disease occurs <5%
      • Rapidly progressive glomerulonephritis (RPGN) is rare, occurring in <1% cases.
      • Most cases resolve spontaneously with no long-term sequelae.
  • Other infectious sources of glomerulonephritis (GN):
    • Sepsis, pneumonia, endocarditis, viruses, HIV
    • Pulmonary, intra-abdominal, or cutaneous infections
    • Syphilis, leprosy, schistosomiasis, and malaria
    • Goal: Treat underlying infection.
  • Hepatitis virus–related glomerular disease:
    • Can present with either nephritic or nephrotic symptoms
    • Causes membranoproliferative GN
    • Complements remain low indefinitely (compared to PSGN)
  • Noninfectious causes of GN (due to immune complex formation):
    • Systematic lupus erythematosus, Henoch–Schönlein purpura, vasculitis, Wegener granulomatosis
    • Goodpasture syndrome
  • IgA nephropathy (IgA-N)
    • Most common cause of AGN (>25%) worldwide
    • Antibody–antigen causes immune complex deposition of IgA and C3
    • Complement levels are usually normal.
    • IgA-N has different presentations:
      • Gross hematuria following upper respiratory infection (URI)
      • Microscopic hematuria with proteinuria
      • Hematuria during viral illness or after exercise
      • Prognosis is related to serum creatinine, BP, and proteinuria.
      • 50% of patients with proteinuria may develop progressive renal disease.
      • ACE inhibitors or angiotensin-receptor blockers (ARBs) may help
  • RPGN:
    • Certain patients with AGN may progress rapidly to renal failure.
    • Hallmarks are crescents on renal biopsy.
  • Hereditary nephritis
    • Alport syndrome
DIAGNOSIS
SIGNS AND SYMPTOMS
  • Hematuria:
    • Abrupt onset gross hematuria in 30–40% (coffee- or cola-colored urine)
  • Edema:
    • Periorbital edema
    • Generalized edema more common in infants and children
  • Infectious source or recent infection: Upper respiratory tract or skin common, e.g., PSGN
  • Symptoms of congestive heart failure:
    • 40% occurrence in patients >60 yr
    • Rare in children
  • Arthritis, arthralgias, and various skin rashes: PSGN, systemic disease
  • Nonspecific manifestations:
    • Malaise
    • Weakness
    • Anorexia
    • Nausea/vomiting
History
  • Recent URI or skin or other infection
  • Change in urine color
Physical-Exam
  • Hypertension
  • Edema
ESSENTIAL WORKUP

Urinalysis with sediment evaluation to detect:

  • RBCs, proteinuria, and RBC casts
  • RBC casts are diagnostic of an active glomerular inflammation.
DIAGNOSIS TESTS & NTERPRETATION
Lab
  • CBC:
    • Anemia (seen in more chronic cases of GN or other systemic disease)
    • Acute leukocytosis (may suggest infectious process)
  • Basic metabolic panel:
    • Assess baseline renal function
    • Check for electrolyte abnormalities
    • GFR will be normal or nearly normal
  • Urinalysis:
    • RBCs +/− casts, protein
  • Serum albumin
  • Cultures (throat, skin, urine, blood):
    • As clinically suspected for infectious source
    • Streptozyme
  • Serum complement level (C3): Decreased in infectious endocarditis, shunt nephritis, and PSGN
  • Streptococcal antibodies:
    • Antistreptolysin (ASO), antistreptokinase (ASK), antideoxyribonuclease B (ADNase B), antinicotinyl adenine dinucleotidase (ANADase), and antihyaluronidase (AH)
    • ASO more reactive in pharyngeal infections
    • ADNase B, ANADase, and AH more reactive in cutaneous infections
    • ASK elevated in recent hemolytic Streptococcus infections
    • Titers do not correlate with prognosis of disease
  • Urine osmolality, sodium, creatinine
  • 24-hr urine collection:
    • Proteinuria initially present in 5% of children, 20% of adults with PSGN
Imaging
  • Renal ultrasound: Kidney size abnormality
  • Chest radiograph: Cardiomegaly, pulmonary edema, infection
Diagnostic Procedures/Surgery

Renal biopsy:

  • Generally not done for PSGN, as symptoms typically resolve after a brief illness
  • Recommended if atypical features of PSGN, persistently abnormal complement levels, persistent hypertension, and proteinuria >3 g/d
  • Facilitates diagnosis for other causes of nephritis
DIFFERENTIAL DIAGNOSIS
  • (See “Glomerulonephritis” for further information on types of GN)
  • Renal:
    • Primary glomerular disease
  • Systemic:
    • Goodpasture syndrome
    • Vasculitis
    • Henoch–Schönlein purpura
  • Other (rare):
    • Hemolytic-uremic syndrome
    • Thrombotic thrombocytopenic purpura
    • Acute hypersensitivity interstitial nephritis
    • Serum sickness
TREATMENT
PRE HOSPITAL

Support ABCs

INITIAL STABILIZATION/THERAPY

ABCs

ED TREATMENT/PROCEDURES
  • Antibiotics for streptococcal infection:
    • Penicillin (erythromycin, if penicillin allergic)
  • Restrict salt and fluid intake
  • Administer loop diuretics (furosemide)
  • Restore urine flow in oliguric patients:
    • Mannitol
  • Treat pulmonary edema:
    • Oxygen
    • Morphine
    • Loop diuretics
  • Stabilize BP to decrease proteinuria, retard progression of GN:
    • ACEIs, ARBs
    • Hypertensive emergency: Nitroprusside or other titratable antihypertensive medication
  • Hemodialysis for:
    • Severe hyperkalemia
    • Fluid overload
    • Uremia
    • Severe acidosis
    • Correct electrolyte abnormalities
MEDICATION
  • Erythromycin: 250–500 mg (peds: 30–50 mg/kg/d) PO q6h for 7–10 days
  • Furosemide: 20–80 mg (peds: 1–6 mg/kg) PO daily/BID
  • Lisinopril (ACEI): 10–40 mg (peds: >6 yr: 0.07 mg/kg) PO daily
  • Losartan (ARB): 25–100 mg (peds: >6 yr: 0.7 mg/kg) PO daily
  • Mannitol: 12.5–100 g (peds: 0.25–0.5 g/kg) IV:
    • May use single or repeat dosing; consider test dosing 1st.
  • Morphine sulfate: 0.1 mg/kg/dose IV q4h
  • Nitroprusside: 0.3–4 μg/kg/min IV
    • Titrate to goal mean arterial pressure for hypertensive emergency.
  • Penicillin:
    • Benzathine penicillin: 1.2 million U (peds: 0.3–0.9 million U, based on weight) IM as single dose
    • Penicillin VK: 250–500 mg (peds: <12 yr 25–50 mg/kg/d) PO q6–8h for 10 days
  • Other agents, including fish oil (ω-3 fatty acids for anti-inflammatory effects) and immunosuppressive agents (glucocorticoids, cyclophosphamide), may be used in consultation with specialists.
FOLLOW-UP
DISPOSITION
Admission Criteria
  • Evidence of infectious cause for GN
  • Oliguria, anuria
  • Uremia
  • Elevated creatinine
  • Edema
  • Electrolyte abnormalities
  • Severe hypertension
  • CHF

Other books

Sleeper Cell by Alan Porter
My Fair Gentleman by Jan Freed
Stark's Command by John G. Hemry
Satan Wants Me by Robert Irwin
Trackers by Deon Meyer
Chasing Orion by Kathryn Lasky
The 2084 Precept by Anthony D. Thompson
The Latte Rebellion by Sarah Jamila Stevenson